About US
Contact us
-
CPhI Worldwide 2011We are delighted to announce the official opening of CPhI Worldwide 2011, taking place at Messe Frankfurt, Germany, from 25 – 27 October. With a substantial global visitor audience, a tailored con2011/2/25
-
ExcipientFest AmericasMay 10 - 11, 2011 - Renaissance Harborplace Hotel, Baltimore, MD Pharma Industry's BEST Event for Regulatory, Science and Sourcing Education ExcipientFest attracts Pharmaceutical Scientists fro2011/2/25
-
US Congressmen Vows to Fight for Drug Market CompetitionUS Congressman Henry Waxman has vowed to fight to promote competition within the pharmaceutical industry, adding that the US Food and Drug Administration's 32-month approval time for generic drugs is2011/2/25
-
Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertensionTakeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application (NDA) to the U.S. Food and Drug Adminis2011/2/25
-
Takeda and Lilly Cooperate with Actos InvestigationThe Attorney General of Texas, US, has requested documents relating to a recall of the diabetes drug Actos from pharmaceutical companies Takeda and Eli Lilly as part of an ongoing investigation into d2011/2/24
-
FDA Approves First Product to Treat Genetic Bleeding DisorderThe US Food and Drug Administration (FDA) has approved CSL Behring's Corifact, the first product intended to prevent bleeding in people with congenital Factor XIII deficiency, a rare genetic defect.2011/2/24
-
GAO Report Faults FDA’s Response to Heparin CrisisAgency’s use of outside experts violated ethics rules Although the U.S. Food and Drug Administration’s (FDA) response to the contamination of heparin sodium in 2008 helped protect the public health2011/2/23
-
Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolioSheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exc2011/2/23
-
Certain uses of terbutaline could lead to maternal heart problems and death, FDA warnsThe U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 h2011/2/22
-
Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition) issuedThe Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition) (hereinafter referred to as the new version of GMP) was recently issued and will come into effect as of March 1, 20112011/2/22